Quantcast
Channel: Форумы для людей с аутоиммунными заболеваниями
Viewing all articles
Browse latest Browse all 8890

Takeda Announces Extension of Fda Pdufa Action Date for Vedolizumab for Ulcerative Co

$
0
0
Food & Drug Administration has extended the Prescription Drug User Fee Act Priority Review action date for the ulcerative colitis indication of Takeda's investigational biologic, vedolizumab.


More...

Viewing all articles
Browse latest Browse all 8890

Trending Articles